J F Delfraissy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J F Delfraissy

Showing results (151-160 of 207) with videos related to

Pageof 21

Sort By:

JAMA|February 5, 1998

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study GroupM Misrahi, J P Teglas, N N'Go, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001

Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patientsY Taoufik, I Peguillet, M G de Goër, et al.

Rapid Communications in Mass Spectrometry : RCM|August 17, 2001

Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometryA Pruvost, F Becher, P Bardouille, et al.

AIDS (London, England)|June 1, 1994

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study GroupN Carré, C Deveau, F Belanger, et al.

AIDS (London, England)|December 28, 2000

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patientsS Guérin, L Meyer, I Theodorou, et al.

AIDS (London, England)|April 15, 1999

Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapyF Martinon, C Michelet, I Peguillet, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunityL Chatenoud, B Dugas, G Beaurain, et al.

American Journal of Obstetrics and Gynecology|July 1, 1994

Thrombocytopenia in pregnant women infected with human immunodeficiency virus: maternal and neonatal outcomeL Mandelbrot, I Schlienger, A Bongain, et al.

AIDS (London, England)|September 26, 1997

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study GroupL Meyer, M Magierowska, J B Hubert, et al.

JAMA|July 11, 1998

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal CohortL Mandelbrot, J Le Chenadec, A Berrebi, et al.

Pageof 21

Search research articles

Showing results (151-160 of 207) with videos related to

Sort By:

Pageof 21

JAMA|February 5, 1998

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study GroupM Misrahi, J P Teglas, N N'Go, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001

Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patientsY Taoufik, I Peguillet, M G de Goër, et al.

Rapid Communications in Mass Spectrometry : RCM|August 17, 2001

Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometryA Pruvost, F Becher, P Bardouille, et al.

AIDS (London, England)|June 1, 1994

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study GroupN Carré, C Deveau, F Belanger, et al.

AIDS (London, England)|December 28, 2000

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patientsS Guérin, L Meyer, I Theodorou, et al.

AIDS (London, England)|April 15, 1999

Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapyF Martinon, C Michelet, I Peguillet, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunityL Chatenoud, B Dugas, G Beaurain, et al.

American Journal of Obstetrics and Gynecology|July 1, 1994

Thrombocytopenia in pregnant women infected with human immunodeficiency virus: maternal and neonatal outcomeL Mandelbrot, I Schlienger, A Bongain, et al.

AIDS (London, England)|September 26, 1997

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study GroupL Meyer, M Magierowska, J B Hubert, et al.

JAMA|July 11, 1998

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal CohortL Mandelbrot, J Le Chenadec, A Berrebi, et al.

Pageof 21